AI assistant
Sending…
GENTEX CORP — Director's Dealing 2018
Feb 20, 2018
30893_dirs_2018-02-20_4273f482-3055-4e20-8102-c9ad0d0f5a8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2018-02-15
Reporting Person: Boehm Neil (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 38632.00 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $15.41 | 2019-03-28 | Common Stock (2686.00) | Direct | |
| Employee Stock Option (Right to Buy) | $18.30 | 2020-03-31 | Common Stock (5640.00) | Direct | |
| Employee Stock Option (Right to Buy) | $15.69 | 2021-03-31 | Common Stock (6210.00) | Direct | |
| Employee Stock Option (Right to Buy) | $22.94 | 2028-02-15 | Common Stock (30000.00) | Direct |
Footnotes
F1: Options granted under the Gentex Corporation Employee Stock Option Plan which is a Rule 16B plan.
F2: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19